Anti-malaria monoclonal antibodies
Latest Information Update: 11 Jan 2024
At a glance
- Originator Sail Biomedicines
- Class Antimalarials; Antiparasitics; Monoclonal antibodies; RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Malaria